article thumbnail

Family Medicine: Finding Its Way on the Federal Research Roadmap [Economic or policy analysis]

Annals of Family Medicine

Study Design and Analysis: We explored the relationship between funding success and multidisciplinarity, examining whether US Departments of FM (DFMs) incorporating diverse disciplines in their names exhibited higher chances of securing research funding. Outcome Measures: Percent of Federal US funding received per year by US DFMs.

article thumbnail

Healthcare Gentrification and Access to Care Equity: Results From a Scoping Review [Health care disparities]

Annals of Family Medicine

What is the relationship between gentrification and access to healthcare? 2010), as well as more recent scoping review methodology guidelines described by Colquhoun (2014). Methods: This scoping review answered the following questions: To what extent has the concept of healthcare gentrification been described in the health literature?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Remembering Holly J. Humphrey, MD, MACP

ABIM

Holly had a long and meaningful relationship with ABIM dating back to her first days on the ABIM Board of Directors in 2001. She served as the chair of the Board from 2006 to 2007 and chair of the ABIM Foundation Board of Trustees from 2014 to 2016. Foundation, passed yesterday from pancreatic cancer.

article thumbnail

Direct Primary Care - Role for the Future of Healthcare

The Direct Doctors Difference

Looking back to 2014, when we began, there were less than 100. The strength also comes from a group of physicians who want something more and something better - improved work-life balance, return of joy to practicing medicine, and a renewal of the pure physician-patient relationship where the doctor knows his or her patient well.

article thumbnail

FDA’s Issues Draft Guidance on Accelerated Approval: A Substantial Evidentiary and Procedural Overhaul to this High-Profile Pathway

FDA Law Blog

Since that time, it was formalized in FDA regulations (21 CFR 314 Subpart H) in 1992, codified in the Food, Drug, & Cosmetic Act by FDAMA (21 USC 356(c)) in 1997, revised by FDASIA in 2012, and described in guidance, most importantly, in the 2014 Expedited Programs for Serious Conditions Drugs and Biologics (2014 Guidance).

Clinic 64
article thumbnail

Get the 4-1-1 on your 1099s: 5th and 7th Circuits Permit Paying Volume-Based Compensation to Independent Sales Agents

FDA Law Blog

The government asserted that Marchetti had relationships with, access to, and influence over doctors, but failed to show that Marchetti exercised any impermissible influence on them. In that decision, a medical laboratory paid Marchetti percentage-based compensation for successful referrals of Medicare patients to the laboratory.

article thumbnail

Critics Suggest FDA Approving Aduhelm Will Erode the “Public Trust”: What About Patients’ Trust?

FDA Law Blog

As someone who studied in the fields of public health, medical sociology, and biomedical ethics, I was impressed with how quickly the pharmaceutical and biotechnology arena caught up with what took many decades to occur in the context of the physician-patient relationship. 25, 2014). When a Patient Speaks (Sept.